136 related articles for article (PubMed ID: 14502474)
21. Monte Carlo calculations on HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor 8-Cl TIBO: contribution of the L100I and Y181C variants to protein stability and biological activity.
Smith MB; Lamb ML; Tirado-Rives J; Jorgensen WL; Michejda CJ; Ruby SK; Smith RH
Protein Eng; 2000 Jun; 13(6):413-21. PubMed ID: 10877852
[TBL] [Abstract][Full Text] [Related]
22. Prediction of binding affinities for TIBO inhibitors of HIV-1 reverse transcriptase using Monte Carlo simulations in a linear response method.
Smith RH; Jorgensen WL; Tirado-Rives J; Lamb ML; Janssen PA; Michejda CJ; Kroeger Smith MB
J Med Chem; 1998 Dec; 41(26):5272-86. PubMed ID: 9857095
[TBL] [Abstract][Full Text] [Related]
23. Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance.
Hsiou Y; Das K; Ding J; Clark AD; Kleim JP; Rösner M; Winkler I; Riess G; Hughes SH; Arnold E
J Mol Biol; 1998 Nov; 284(2):313-23. PubMed ID: 9813120
[TBL] [Abstract][Full Text] [Related]
24. Quantitative structure-activity relationships and comparative molecular field analysis of TIBO derivatised HIV-1 reverse transcriptase inhibitors.
Hannongbua S; Pungpo P; Limtrakul J; Wolschann P
J Comput Aided Mol Des; 1999 Nov; 13(6):563-77. PubMed ID: 10584215
[TBL] [Abstract][Full Text] [Related]
25. Models which explain the inhibition of reverse transcriptase by HIV-1-specific (thio)carboxanilide derivatives.
Esnouf RM; Stuart DI; De Clercq E; Schwartz E; Balzarini J
Biochem Biophys Res Commun; 1997 May; 234(2):458-64. PubMed ID: 9177293
[TBL] [Abstract][Full Text] [Related]
26. Probing furanose ring conformation by gas-phase computational methods: energy profile and structural parameters in methyl beta-D-arabinofuranoside as a function of ring conformation.
Gordon MT; Lowary TL; Hadad CM
J Org Chem; 2000 Aug; 65(16):4954-63. PubMed ID: 10956478
[TBL] [Abstract][Full Text] [Related]
27. A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templates.
White EL; Buckheit RW; Ross LJ; Germany JM; Andries K; Pauwels R; Janssen PA; Shannon WM; Chirigos MA
Antiviral Res; 1991 Oct; 16(3):257-66. PubMed ID: 1725247
[TBL] [Abstract][Full Text] [Related]
28. Colorimetric assays for evaluation of the mode of action of human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors.
Shao X; Rytting AS; Ekstrand DH; Vrang L; Källander CF; Gronowitz JS
Antivir Chem Chemother; 1998 Mar; 9(2):167-76. PubMed ID: 9875388
[TBL] [Abstract][Full Text] [Related]
29. Non-nucleoside inhibitors of HIV-1 reverse transcriptase: molecular modeling and X-ray structure investigations.
Schäfer W; Friebe WG; Leinert H; Mertens A; Poll T; von der Saal W; Zilch H; Nuber B; Ziegler ML
J Med Chem; 1993 Mar; 36(6):726-32. PubMed ID: 7681480
[TBL] [Abstract][Full Text] [Related]
30. Structure and conformational analysis of the anti-HIV reverse transcriptase inhibitor AZT using MP2 and DFT methods. Differences with the natural nucleoside thymidine. Simulation of the 1st phosphorylation step with ATP.
Palafox MA
Phys Chem Chem Phys; 2014 Dec; 16(45):24763-83. PubMed ID: 25317835
[TBL] [Abstract][Full Text] [Related]
31. CoMFA 3D-QSAR analysis of HIV-1 RT nonnucleoside inhibitors, TIBO derivatives based on docking conformation and alignment.
Zhou Z; Madura JD
J Chem Inf Comput Sci; 2004; 44(6):2167-78. PubMed ID: 15554687
[TBL] [Abstract][Full Text] [Related]
32. Conformational study of the HIV-1 reverse transcriptase inhibitor 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT).
Lawtrakul L; Hannongbua S; Beyer A; Wolschann P
Biol Chem; 1999 Feb; 380(2):265-7. PubMed ID: 10195434
[TBL] [Abstract][Full Text] [Related]
33. Molecular structure and vibrational bands and chemical shift assignments of 4-allyl-5-(2-hydroxyphenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione by DFT and ab initio HF calculations.
Karakurt T; Dinçer M; Cetin A; Sekerci M
Spectrochim Acta A Mol Biomol Spectrosc; 2010 Sep; 77(1):189-98. PubMed ID: 20542728
[TBL] [Abstract][Full Text] [Related]
34. Strategies for the design of HIV-1 non-nucleoside reverse transcriptase inhibitors: lessons from the development of seven representative paradigms.
Li D; Zhan P; De Clercq E; Liu X
J Med Chem; 2012 Apr; 55(8):3595-613. PubMed ID: 22268494
[No Abstract] [Full Text] [Related]
35. Conformational analysis of the anti-HIV Nikavir prodrug: comparisons with AZT and Thymidine, and establishment of structure-activity relationships/tendencies in other 6'-derivatives.
El-Sayed AA; Tamara Molina A; Álvarez-Ros MC; Alcolea Palafox M
J Biomol Struct Dyn; 2015; 33(4):723-48. PubMed ID: 24762127
[TBL] [Abstract][Full Text] [Related]
36. Conformational characterization of lanthanide(III)-DOTA complexes by ab initio investigation in vacuo and in aqueous solution.
Cosentino U; Villa A; Pitea D; Moro G; Barone V; Maiocchi A
J Am Chem Soc; 2002 May; 124(17):4901-9. PubMed ID: 11971741
[TBL] [Abstract][Full Text] [Related]
37. Experimental and theoretical study on diethyl-(Z)-2-(5,7-diphenyl-1,3,4-oxadiazepin-2-yl)-2-butenedioate using different levels of computational methods.
Asadi Z; Asnaashariisfahani MB; Vessally E; Esrafili MD
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Apr; 140():585-99. PubMed ID: 25656391
[TBL] [Abstract][Full Text] [Related]
38. Binding energy analysis for wild-type and Y181C mutant HIV-1 RT/8-Cl TIBO complex structures: quantum chemical calculations based on the ONIOM method.
Saen-oon S; Kuno M; Hannongbua S
Proteins; 2005 Dec; 61(4):859-69. PubMed ID: 16245320
[TBL] [Abstract][Full Text] [Related]
39. Conformational stability from variable temperature infrared spectra of krypton solutions, ab initio calculations, vibrational assignment, and r0 structural parameters of 1,3-difluoropropane.
Durig JR; Zheng C; Williams MJ; Stidham HD; Guirgis GA
Spectrochim Acta A Mol Biomol Spectrosc; 2004 Jun; 60(7):1659-76. PubMed ID: 15147712
[TBL] [Abstract][Full Text] [Related]
40. Resistance of human immunodeficiency virus type 1 reverse transcriptase to TIBO derivatives induced by site-directed mutagenesis.
de Vreese K; Debyser Z; Vandamme AM; Pauwels R; Desmyter J; de Clercq E; Anné J
Virology; 1992 Jun; 188(2):900-4. PubMed ID: 1374986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
